Myelodysplastic Syndromes (MDS)
Overview
Myelodysplastic syndromes are a group of diseases where a person’s bone marrow fails to produce enough healthy blood cells, and instead produces immature blood cells called blasts.
Common Signs And Symptoms
- Easy Bruising Or Bleeding
- Frequent Infections
- Pinhead Sized Red Spots On The Skin Petechiae
- Fatigue
- Paleness Of Skin
- Shortness Of Breath
People with myelodysplastic syndromes may experience a variety of symptoms including:
Types of Myelodysplastic Syndromes (MDS)
There are two main categories of MDS: lower-risk and higher-risk. The type of MDS an individual has is defined by the number of blasts that are in their bone marrow, which determines the severity. Blasts refer to abnormal immature white blood cells, and people with MDS have too many blasts in their bone marrow.
- Lower-Risk MDSLower-risk MDS is defined as having less than 5 blasts out of 100 white blood cells in the bone marrow.
- Higher-Risk MDSHigher-risk MDS is defined as having between 5 and 19 blasts out of 100 white blood cells in the bone marrow.
An individual is diagnosed with acute myelogenous leukemia (AML) when there are 20 or more blasts per 100 white blood cells in the bone marrow.
Diagnosis Journey
The following tests can be used to confirm a diagnosis of MDS:
Treatment Options
Treatment and management options for MDS include:
- 01Blood TransfusionsRegular blood transfusions help provide the patient with a healthy amount of blood cells from donors to relieve symptoms of anemia.
- 02Stem Cell/Bone Marrow TransplantsA bone marrow transplant gives patients healthy stem cells to replace the diseased bone marrow.
- 03ChemotherapyChemotherapy can help reduce the abnormal stem cells and allow healthy stem cells to grow back. MDS can progress to acute leukemia, so MDS patients may be treated with chemotherapy as that is a common treatment option for leukemia.
- 04Growth Factor InjectionsChemotherapy can help reduce the abnormal stem cells and allow healthy stem cells to grow back. MDS can progress to acute leukemia, so MDS patients may be treated with chemotherapy as that is a common treatment option for leukemia.
- 05MedicationsMedications for MDS can help stimulate blood cells to mature, control immune system, and treat infections.
Ongoing Research
MDS is a rare disease that requires more effective treatment options. To find these new treatments for MDS, further research is necessary.
Current Research Studies
There are about 350 MDS research studies that are actively recruiting participants. Visit ClinicalTrials.gov to find MDS research studies near you.
Research & Resources
- Community Groups
- Advocacy Groups
- Podcasts & Websites
- Mental Health & Disability Resources
- Research Articles
- MDS FoundationLearn More
- MDS AllianceLearn More
- The Aplastic Anemia Mds International FoundationLearn More
- Blood Cancer UnitedFormerly known as The Leukemia and Lymphoma SocietyLearn More
- Healthtree Foundation For Myelodysplastic SyndromesLearn More





